Arbor Biotechnologies, Inc. — Form D

Arbor Biotechnologies, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-10. The offering totals $215.0M, of which $215.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
MARK ANGELINODirectorCAMBRIDGE, MA
Keith CrandellDirectorSunnyvale, CA
RAMI HARAWIDirectorCAMBRIDGE, MA
Paul MeisterDirectorWaltham, MA
DEVYN SMITHDirectorCAMBRIDGE, MA
David WaltDirectorCambridge, MA
CHEN YUDirectorPALO ALTO, CA
DAVID CHENGExecutive OfficerHayward, CA
Kelly MorganExecutive OfficerLas Vegas, NV
John MurphyExecutive OfficerBeaver Falls, PA
DEVYN SMITHExecutive OfficerCAMBRIDGE, MA
PAM STETKIEWICZExecutive OfficerCAMBRIDGE, MA
David R WaltDirectorBillerica, MA
KEITH XIA CRANDELLDirectorCAMBRIDGE, MA
DAVID ARTHUR SCOTTExecutive OfficerCAMBRIDGE, MA
WINSTON XIA YANExecutive OfficerCAMBRIDGE, MA
ANNIE XIA HAZLEHURSTDirectorCAMBRIDGE, MA
FENG R ZHANGDirectorCAMBRIDGE, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2017-08-02D/A$15.6M$15.6M
2017-06-01D$15.6M$12.2M

More